A role for P-glycoprotein in regulating cell growth and survival

Clinical and Applied Immunology Reviews

Volumn 4, Issue 1, 2003, Pages 31-47

  Ruefli, Astrid A ^a   Johnstone, Ricky W ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Apoptosis; Multidrug resistance; P glycoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; APOPTOSIS INHIBITOR; CASPASE; CELL SURFACE PROTEIN; CERAMIDE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; FAS LIGAND; GLYCOPROTEIN P; HEXAMETHYLENEBISACETAMIDE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE; VORINOSTAT;

CELL DEATH; CELL GROWTH; CELL MEMBRANE DEPOLARIZATION; CELL PROTECTION; CELL SURVIVAL; ENZYME ACTIVATION; MULTIDRUG RESISTANCE; POTASSIUM TRANSPORT; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TUMOR CELL; TUMOR CELL DESTRUCTION;

EID: 0038309194     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(03)00005-9     Document Type: Review

References (93)

1. Gottesman M.M. Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 62 1993 385-427
2. Ambudkar S.V. Dey S. Hrycyna C.A. Ramachandra M. Pastan I. Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu Rev Pharmacol Toxicol 39 1999 361-398
3. Cordon-Cardo C. O'Brien J.P. Casals D. Rittman-Grauer L. Biedler J.L. Melamed M.R. et al Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc Natl Acad Sci USA 86 2 1989 695-698
4. Thiebaut F. Tsuruo T. Hamada H. Gottesman M.M. Pastan I. Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc Natl Acad Sci USA 84 21 1987 7735-7738
5. Chaudhary P.M. Roninson I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells Cell 66 1 1991 85-94
6. Strasser A. O'Connor L. Dixit V.M. Apoptosis signaling Annu Rev Biochem 69 2000 217-245
7. Muzio M. et al FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 6 1996 817-827
8. Medema J.P. Scaffidi C. Kischkel F.C. Shevchenko A. Mann M. Krammer P.H. et al FLICE is activated by association with the CD95 death-inducing signaling complex (DISC) EMBO J 16 10 1997 2794-2804
9. Li H. Zhu H. Xu C.J. Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 94 4 1998 491-501
10. Luo X. Budihardjo I. Zou H. Slaughter C. Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 94 4 1998 481-490
11. Green D.R. Reed J.C. Mitochondria and apoptosis Science 281 5381 1998 1309-1312
12. Trapani J.A. Jans D.A. Jans P.J. Smyth M.J. Browne K.A. Sutton V.R. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent J Biol Chem 273 43 1998 27934-27938
13. Deas O. Dumont C. MacFarlane M. Rouleau M. Hebib C. Harper F. et-al Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes J Immunol 161 7 1998 3375-3383
14. Bossy-Wetzel E. Newmeyer D.D. Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization EMBO J 17 1 1998 37-49
15. Miller T.M. Moulder K.L. Knudson C.M. Creedon D.J. Deshmukh M. Korsmeyer S.J. et al Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death J Cell Biol 139 1 1997 205-217
16. Ruefli A.A. Smyth M.J. Johnstone R.W. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance Blood 95 7 2000 2378-2385
17. Ruefli A.A. Ausserlechner M.J. Bernhard D. Sutton V.R. Tainton K.M. Kofler R. et al The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species Proc Natl Acad Sci USA 98 19 2001 10833-10838
18. Leist M. Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms Nat Rev Mol Cell Biol 2 8 2001 589-598
19. Okuno S. Shimizu S. Ito T. Nomura M. Hamada E. Tsujimoto Y. et al Bcl-2 prevents caspase-independent cell death J Biol Chem 273 51 1998 34272-34277
20. Miyashita T. Reed J.C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line Blood 81 1 1993 151-157
21. Friesen C. Herr I. Krammer P.H. Debatin K.M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells Nat Med 2 5 1996 574-577
22. Friesen C. Fulda S. Debatin K.M. Cytotoxic drugs and the CD95 pathway Leukemia 13 11 1999 1854-1858
23. Fulda S. Los M. Friesen C. Debatin K.M. Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system Int J Cancer 76 1 1998 105-114
24. Herr I. Wilhelm D. Bohler T. Angel P. Debatin K.M. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis EMBO J 16 20 1997 6200-6208
25. Los M. Herr I. Friesen C. Fulda S. Schulze-Osthoff K. Debatin K.M. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases) Blood 90 8 1997 3118-3129
26. Jaffrezou J.P. Levade T. Bettaieb A. Andrieu N. Bezombes C. Maestre N. et al Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis EMBO J 15 10 1996 2417-2424
27. Hofmann K. Dixit V.M. Ceramide in apoptosis-does it really matter? Trends Biochem Sci 23 10 1998 374-377
28. Cremesti A. Paris F. Grassme H. Holler N. Tschopp J. Fuks Z. et al Ceramide enables fas to cap and kill J Biol Chem 276 26 2001 23954-23961
29. Paris F. Grassme H. Cremesti A. Zager J. Fong Y. Haimovitz-Friedman A. et al Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes J Biol Chem 276 11 2001 8297-8305
30. Thome M. et al Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors Nature 386 6624 1997 517-521
31. Zhou Q. Snipas S. Orth K. Muzio M. Dixit V.M. Salvesen G.S. Target protease specificity of the viral serpin CrmA. Analysis of five caspases J Biol Chem 272 12 1997 7797-7800
32. Pirollo K.F. Bouker K.B. Chang E.H. Does p53 status influence tumor response to anticancer therapies? Anticancer Drugs 11 6 2000 419-432
33. Soengas M.S. et al Inactivation of the apoptosis effector Apaf-1 in malignant melanoma Nature 409 6817 2001 207-211
34. Reed J.C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance Curr Opin Oncol 7 6 1995 541-546
35. Cho J. Lee Y. Lutzky J. Redpath L. Slater L. Collateral sensitivity to radiation and cis-platinum in a multidrug-resistant human leukemia cell line Cancer Chemother Pharmacol 37 1-2 1995 168-172
36. Denecke J. Fiedler K. Hacker-Klom U. Molenkamp G. Jurgens H. Wolff J.E. Multiple drug-resistant C6 glioma cells cross-resistant to irradiation Anticancer Res 17 6D 1997 4531-4534
37. van Helvoort A. Smith A.J. Sprong H. Fritzsche I. Schinkel A.H. Borst P. et al MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine Cell 87 3 1996 507-517
38. Bezombes C. Maestre N. Laurent G. Levade T. Bettaieb A. Jaffrezou J.P. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833 FASEB J 12 1 1998 101-109
39. Pallis M. Russell N. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway Blood 95 9 2000 2897-2904
40. Lenardo M. Chan K.M. Hornung F. McFarland H. Siegel R. Wang J. et al Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment Annu Rev Immunol 17 1999 221-253
41. Siegel R.M. Chan F.K. Chun H.J. Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity Nat Immunol 1 6 2000 469-474
42. Watanabe D. Suda T. Nagata S. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells Int Immunol 7 12 1995 1949-1956
43. Smyth M.J. Krasovskis E. Sutton V.R. Johnstone R.W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis Proc Natl Acad Sci USA 95 12 1998 7024-7029
44. Johnstone R.W. Cretney E. Smyth M.J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death Blood 93 3 1999 1075-1085
45. Cullen K. Davey R. Davey M. The drug resistance proteins, multidrug resistance-associated protein and P-glycoprotein, do not confer resistance to Fas-induced cell death Cytometry 43 3 2001 189-194
46. Cullen K.V. Davey R.A. Davey M.W. Drug resistance does not correlate with resistance to Fas-mediated apoptosis Leuk Res 25 1 2001 69-75
47. Matarrese P. Testa U. Cauda R. Vella S. Gambardella L. Malorni W. Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis Biochem J 355 Pt 3 2001 587-595
48. Gollapudi S. Gupta S. Anti-P-glycoprotein antibody induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival Clin Immunol 2003 In press
49. Hill B.T. Deuchars K. Hosking L.K. Ling V. Whelan R.D. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro J Natl Cancer Inst 82 7 1990 607-612
50. Shimm D.S. Olson S. Hill A.B. Radiation resistance in a multidrug resistant human T-cell leukemia line Int J Radiat Oncol Biol Phys 15 4 1988 931-936
51. Mazzanti R. Fantappie O. Fabrizio P. Pacini S. Relli P. Casamassima F. et al Conferring drug resistance by MDR1 gene transfection increases susceptibility to irradiation and lipid peroxidation in 3T3 cell line Free Radic Biol Med 20 4 1996 601-606
52. Ruth A.C. Roninson I.B. Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation Cancer Res 60 10 2000 2576-2578
53. Marks P.A. Richon V.M. Kiyokawa H. Rifkind R.A. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process Proc Natl Acad Sci USA 91 22 1994 10251-10254
54. Richon V.M. Russo P. Venta-Perez G. Cordon-Cardo C. Rifkind R.A. Marks P.A. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells Cancer Res 57 13 1997 2789-2798
55. Vrana J.A. Decker R.H. Johnson C.R. Wang Z. Jarvis W.D. Richon V.M. et al Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53 Oncogene 18 50 1999 7016-7025
56. Siegel D.S. Zhang X. Feinman R. Teitz T. Zelenetz A. Richon V.M. et al Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells Proc Natl Acad Sci USA 95 1 1998 162-166
57. Aihara M. Aihara Y. Schmidt-Wolf G. Schmidt-Wolf I. Sikic B.I. Blume K.G. et al A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy Blood 77 9 1991 2079-2084
58. Tsuruo T. Hamada H. Sato S. Heike Y. Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies Jpn J Cancer Res 80 7 1989 627-631
59. Bomstein Y. Fishelson Z. Enhanced sensitivity of P-glycoprotein-positive multidrug resistant tumor cells to complement-mediated lysis Eur J Immunol 27 9 1997 2204-2211
60. Weisburg J.H. Curcio M. Caron P.C. Raghu G. Mechetner E.B. Roepe P.D. et al The multidrug resistance phenotype confers immunological resistance J Exp Med 183 6 1996 2699-2704
61. Weisburg J.H. Roepe P.D. Dzekunov S. Scheinberg D.A. Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells J Biol Chem 274 16 1999 10877-10888
62. Morgan B.P. Regulation of the complement membrane attack pathway Crit Rev Immunol 19 3 1999 173-198
63. Johnstone R.W. Tainton K.M. Ruefli A.A. Froelich C.J. Cerruti L. Jane S.M. et al P-glycoprotein does not protect cells against cytolysis induced by pore-forming proteins J Biol Chem 276 20 2001 16667-16673
64. Hoffman M.M. Wei L.Y. Roepe P.D. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J Gen Physiol 108 4 1996 295-313
65. Wadkins R.M. Roepe P.D. Biophysical aspects of P-glycoprotein-mediated multidrug resistance Int Rev Cytol 171 1997 121-165
66. Gottlieb R.A. Nordberg J. Skowronski E. Babior B.M. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification Proc Natl Acad Sci USA 93 2 1996 654-658
67. Stennicke H.R. Salvesen G.S. Biochemical characteristics of caspases-3, -6, -7, and -8 J Biol Chem 272 41 1997 25719-25723
68. Roy S. Bayly C.I. Gareau Y. Houtzager V.M. Kargman S. Keen S.L. et al Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide Proc Natl Acad Sci USA 98 11 2001 6132-6137
69. Segal M.S. Beem E. Effect of pH, ionic charge, and osmolality on cytochrome c-mediated caspase-3 activity Am J Physiol Cell Physiol 281 4 2001 C1196-C1204
70. Liu D. Martino G. Thangaraju M. Sharma M. Halwani F. Shen S.H. et al Caspase-8-mediated intracellular acidification precedes mitochondrial dysfunction in somatostatin-induced apoptosis J Biol Chem 275 13 2000 9244-9250
71. Matsuyama S. Llopis J. Deveraux Q.L. Tsien R.Y. Reed J.C. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis Nat Cell Biol 2 6 2000 318-325
72. Robinson L.J. Roberts W.K. Ling T.T. Lamming D. Sternberg S.S. Roepe P.D. Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts Biochemistry 36 37 1997 11169-11178
73. Barriere H. Poujeol C. Tauc M. Blasi J.M. Counillon L. Poujeol P. CFTR modulates programmed cell death by decreasing intracellular pH in Chinese hamster lung fibroblasts Am J Physiol Cell Physiol 281 3 2001 C810-C824
74. Gottlieb R.A. Dosanjh A. Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis Proc Natl Acad Sci USA 93 8 1996 3587-3591
75. Idriss H.T. Hannun Y.A. Boulpaep E. Basavappa S. Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say! J Physiol 524 Pt 3 2000 629-636
76. Valverde M.A. Bond T.D. Hardy S.P. Taylor J.C. Higgins C.F. Altamirano J. et al The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease EMBO J 15 17 1996 4460-4468
77. Higgins C.F. Volume-activated chloride currents associated with the multidrug resistance P-glycoprotein J Physiol 482 1995 31S-36S
78. Bortner C.D. Cidlowski J.A. Caspase independent/dependent regulation of K(+), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis J Biol Chem 274 31 1999 21953-21962
79. Bortner C.D. Hughes F.M.Jr. Cidlowski J.A. A primary role for K+ and Na+ efflux in the activation of apoptosis J Biol Chem 272 51 1997 32436-32442
80. Schinkel A.H. Smit J.J. van Tellingen O. Beijnen J.H. Wagenaar E. van Deemter L. et al Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 77 4 1994 491-502
81. Schinkel A.H. et al Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins Proc Natl Acad Sci USA 94 8 1997 4028-4033
82. Eisenbraun M.D. Miller R.A. mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cytotoxic effector function in mice J Immunol 163 5 1999 2621-2627
83. Eisenbraun M.D. Mosley R.L. Teitelbaum D.H. Miller R.A. Altered development of intestinal intraepithelial lymphocytes in P-glycoprotein-deficient mice Dev Comp Immunol 24 8 2000 783-795
84. Panwala C.M. Jones J.C. Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis J Immunol 161 10 1998 5733-5744
85. Lee C.G. Ramachandra M. Jeang K.T. Martin M.A. Pastan I. Gottesman M.M. Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter FASEB J 14 3 2000 516-522
86. Raviv Y. Puri A. Blumenthal R. P-glycoprotein-overexpressing multidrug-resistant cells are resistant to infection by enveloped viruses that enter via the plasma membrane FASEB J 14 3 2000 511-515
87. Bunting K.D. Galipeau J. Topham D. Benaim E. Sorrentino B.P. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice Blood 92 7 1998 2269-2279
88. Bunting K.D. Zhou S. Lu T. Sorrentino B.P. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo Blood 96 3 2000 902-909
89. Goodell M.A. Rosenzweig M. Kim H. Marks D.F. DeMaria M. Paradis G. et al Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species Nat Med 3 12 1997 1337-1345
90. Bhatia M. Bonnet D. Murdoch B. Gan O.I. Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity Nat Med 4 9 1998 1038-1345
91. Zanjani E.D. Almeida-Porada G. Livingston A.G. Flake A.W. Ogawa M. Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells Exp Hematol 26 4 1998 353-360
92. Williams D.A. Ex vivo expansion of hematopoietic stem and progenitor cells-robbing Peter to pay Paul? Blood 81 12 1993 3169-3172
93. Traycoff C.M. Orazi A. Ladd A.C. Rice S. McMahel J. Srour E.F. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells Exp Hematol 26 1 1998 53-62